Thursday 14 December 2017
Contact US    |    Archive
PR
2 months ago

Prometic Announces FDA Acceptance of its Biologics License Application for Plasminogen (Ryplazim™)

Prescription Drug User Fee Act (PDUFA) action date is set for April 14, 2018 Ryplazim™ previous

Read on the original site


Hashtags:   

Prometic

 | 

Announces

 | 

FDA

 | 

Acceptance

 | 

its

 | 

Biologics

 | 

License

 | 

Application

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
All Countries